Work

NANORAY-312: A Phase III Pivotal Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-Based Chemotherapy-Ineligible Elderly Patients with Locally Advanced HNSCC

Year: 2022

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2022.07.1372

Authors: S.S. Yom, Z. Takacsi-Nagy, X. Liem, S. Salas, A. Debard, L. Finzi, O.I. Vivar, L.A. Farber, M. Gogishvili, G. Kristesashvili, T. Makharadze, C. Hoffmann, C. Le Tourneau

Institutions: University of California, San Francisco, National Institute of Oncology, Université de Montréal, Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Nanobiotix (France), Tbilisi State Medical University, Institut Curie

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4307148372

FWCI: 1.638

Cites:

Cited by: 8

Related to: 10